Rhinoplasty. General- and plastic-surgery devices associated with adverse incidents
Conditions
Interventions
Intervention 1: Intervention group 1: People receiving remifentanil 0.1-0.3 µg / kg / min at the same time as anesthesia before and during rhinoplasty Intervention. Intervention 2: "Intervention group
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1-Age between 18 and 45 years 2- Classification of the American Anesthesia Association in Physical Classes 1 and 2 3- Satisfaction of the company in the project 4-No history of bleeding disorders in the patient 5-No history of hypertension in the patient 6-Do not take drugs that alter coagulation profiles such as aspirin 7-Platelet counts and normal coagulation tests
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Before, during and after rhinoplasty. Method of measurement: The vital signs monitoring device of Mizan Teb Company. | — |
Secondary
| Measure | Time frame |
|---|---|
| The surgeon's satisfaction with the surgical site. Timepoint: Before, during and after rhinoplasty. Method of measurement: Vital Signs Monitoring Company of Mizan Teb Company. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Lotfollah Afzali
Shahre-kord University of Medical Sciences
Outcome results
None listed